BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong CM, Ng IO. Molecular pathogenesis of hepatocellular carcinoma. Liver Int. 2008;28:160-174. [PMID: 18069974 DOI: 10.1111/j.1478-3231.2007.01637.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 94] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Moreira AJ, Rodrigues GR, Bona S, Fratta LXS, Weber GR, Picada JN, dos Santos JL, Cerski CT, Marroni CA, Marroni NP. Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats. Protoplasma 2017;254:911-20. [DOI: 10.1007/s00709-016-1000-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ju HL, Ahn SH, Kim DY, Baek S, Chung SI, Seong J, Han KH, Ro SW. Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging. PLoS One 2013;8:e59869. [PMID: 23555816 DOI: 10.1371/journal.pone.0059869] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
4 Chen HQ, Zhao J, Li Y, He LX, Huang YJ, Shu WQ, Cao J, Liu WB, Liu JY. Gene expression network regulated by DNA methylation and microRNA during microcystin-leucine arginine induced malignant transformation in human hepatocyte L02 cells. Toxicol Lett 2018;289:42-53. [PMID: 29518473 DOI: 10.1016/j.toxlet.2018.03.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
5 Teufel A, Marquardt JU, Staib F, Galle PR. Snapshot liver transcriptome in hepatocellular carcinoma. Journal of Hepatology 2012;56:990-2. [DOI: 10.1016/j.jhep.2011.08.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
6 Palagyi A, Neveling K, Plinninger U, Ziesch A, Targosz BS, Denk GU, Ochs S, Rizzani A, Meier D, Thasler WE, Hanenberg H, De Toni EN, Bassermann F, Schäfer C, Göke B, Schindler D, Gallmeier E. Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents. Mol Cancer 2010;9:127. [PMID: 20509860 DOI: 10.1186/1476-4598-9-127] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
7 Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Liver Int. 2009;29:1162-1170. [PMID: 19627485 DOI: 10.1111/j.1478-3231.2009.02082.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
8 Mahmoudian-Sani MR, Asgharzade S, Alghasi A, Saeedi-Boroujeni A, Adnani Sadati SJ, Moradi MT. MicroRNA-122 in patients with hepatitis B and hepatitis B virus-associated hepatocellular carcinoma. J Gastrointest Oncol 2019;10:789-96. [PMID: 31392060 DOI: 10.21037/jgo.2019.02.14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Zhang ZY, Chen LL, Xu W, Sigdel K, Jiang XT. Effects of silencing endothelin-1 on invasion and vascular formation in lung cancer. Oncol Lett 2017;13:4390-6. [PMID: 28599441 DOI: 10.3892/ol.2017.6027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
10 Trinchet J. Carcinome hépatocellulaire : une incidence croissante, une prise en charge « optimisée ». Gastroentérologie Clinique et Biologique 2009;33:830-9. [DOI: 10.1016/j.gcb.2009.04.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Yahya SMM, Fathy SA, El-Khayat ZA, El-Toukhy SE, Hamed AR, Hegazy MGA, Nabih HK. Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma. Indian J Clin Biochem 2018;33:21-30. [PMID: 29371766 DOI: 10.1007/s12291-017-0651-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yu XJ, Fang F, Tang CL, Yao L, Yu L, Yu L. dbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma. Hum Mutat. 2011;32:E2308-E2316. [PMID: 21936021 DOI: 10.1002/humu.21595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
13 Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol. 2014;49:589-593. [PMID: 24531873 DOI: 10.1007/s00535-014-0932-4] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 9.1] [Reference Citation Analysis]
14 Vertemati M, Moscheni C, Petrella D, Lamperti L, Cossa M, Gambacorta M, Goffredi M, Vizzotto L. Morphometric analysis of hepatocellular nodular lesions in HCV cirrhosis. Pathol Res Pract. 2012;208:240-244. [PMID: 22429827 DOI: 10.1016/j.prp.2012.02.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
15 Au SL, Wong CC, Lee JM, Fan DN, Tsang FH, Ng IO, Wong CM. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology. 2012;56:622-631. [PMID: 22370893 DOI: 10.1002/hep.25679] [Cited by in Crossref: 193] [Cited by in F6Publishing: 192] [Article Influence: 19.3] [Reference Citation Analysis]
16 Facciorusso A, Licinio R, Carr BI, Di Leo A, Barone M. MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2015;9:993-1003. [PMID: 25915713 DOI: 10.1586/17474124.2015.1040763] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
17 Bhatia D, Thoppil RJ, Mandal A, Samtani KA, Darvesh AS, Bishayee A. Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway. Evid Based Complement Alternat Med 2013;2013:371813. [PMID: 23606879 DOI: 10.1155/2013/371813] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
18 Darvesh AS, Bishayee A. Chemopreventive and Therapeutic Potential of Tea Polyphenols in Hepatocellular Cancer. Nutrition and Cancer 2013;65:329-44. [DOI: 10.1080/01635581.2013.767367] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
19 Yue PY, Wong YY, Wong KY, Tsoi YK, Leung KS. Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea. Chin Med 2013;8:21. [PMID: 24180549 DOI: 10.1186/1749-8546-8-21] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
20 Giakoustidis A, Giakoustidis D, Mudan S, Sklavos A, Williams R. Molecular signalling in hepatocellular carcinoma: Role of and crosstalk among WNT/ß-catenin, Sonic Hedgehog, Notch and Dickkopf-1. Can J Gastroenterol Hepatol 2015;29:209-17. [PMID: 25965442 DOI: 10.1155/2015/172356] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
21 Wong CM, Tsang FH, Ng IO. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol. 2018;15:137-151. [PMID: 29317776 DOI: 10.1038/nrgastro.2017.169] [Cited by in Crossref: 157] [Cited by in F6Publishing: 174] [Article Influence: 39.3] [Reference Citation Analysis]
22 Zheng Y, Nie P, Xu S. Long noncoding RNA linc00467 plays an oncogenic role in hepatocellular carcinoma by regulating the miR-18a-5p/NEDD9 axis. J Cell Biochem 2020;121:3135-44. [PMID: 31916278 DOI: 10.1002/jcb.29581] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Kumar M, Zhao X, Wang XW. Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci. 2011;1:5. [PMID: 21711594 DOI: 10.1186/2045-3701-1-5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
24 Alsaied OA, Sangwan V, Banerjee S, Krosch TC, Chugh R, Saluja A, Vickers SM, Jensen EH. Sorafenib and triptolide as combination therapy for hepatocellular carcinoma. Surgery 2014;156:270-9. [PMID: 24953273 DOI: 10.1016/j.surg.2014.04.055] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
25 Yuan SX, Wang J, Yang F, Tao QF, Zhang J, Wang LL, Yang Y, Liu H, Wang ZG, Xu QG, Fan J, Liu L, Sun SH, Zhou WP. Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. Hepatology. 2016;63:499-511. [PMID: 25964079 DOI: 10.1002/hep.27893] [Cited by in Crossref: 220] [Cited by in F6Publishing: 239] [Article Influence: 31.4] [Reference Citation Analysis]
26 Shi XH, Zheng Y, Sun Q, Cui J, Liu QH, Qü F, Wang YS. DEC1 nuclear expression: A marker of differentiation grade in hepatocellular carcinoma. World J Gastroenterol 2011; 17(15): 2037-2043 [PMID: 21528084 DOI: 10.3748/wjg.v17.i15.2037] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
27 Schmieder R, Puehler F, Neuhaus R, Kissel M, Adjei AA, Miner JN, Mumberg D, Ziegelbauer K, Scholz A. Allosteric MEK1/2 inhibitor refametinib (BAY 86-9766) in combination with sorafenib exhibits antitumor activity in preclinical murine and rat models of hepatocellular carcinoma. Neoplasia. 2013;15:1161-1171. [PMID: 24204195 DOI: 10.1593/neo.13812] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
28 Yu F, Hao X, Zhao H, Ge C, Yao M, Yang S, Li J. Delta-like 1 contributes to cell growth by increasing the interferon-inducible protein 16 expression in hepatocellular carcinoma. Liver International 2010;30:703-14. [DOI: 10.1111/j.1478-3231.2010.02214.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
29 Vinken M, Vanhaecke T, Rogiers V. Junctional structures and hepatocellular carcinoma: from the lab to the clinic? Liver Int 2008;28:432-4. [PMID: 18339070 DOI: 10.1111/j.1478-3231.2008.01707.x] [Reference Citation Analysis]
30 Wang BB, Cheng JY, Gao HH, Zhang Y, Chen ZN, Bian H. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis. Anat Rec (Hoboken). 2010;293:1492-1496. [PMID: 20652939 DOI: 10.1002/ar.21173] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
31 McClendon AK, Dean JL, Ertel A, Fu Z, Rivadeneira DB, Reed CA, Bourgo RJ, Witkiewicz A, Addya S, Mayhew CN. RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage. Gastroenterology. 2011;141:1439-1450. [PMID: 21704587 DOI: 10.1053/j.gastro.2011.06.046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
32 Nejak-Bowen KN, Monga SP. Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol. 2011;21:44-58. [PMID: 21182948 DOI: 10.1016/j.semcancer.2010.12.010] [Cited by in Crossref: 170] [Cited by in F6Publishing: 163] [Article Influence: 14.2] [Reference Citation Analysis]
33 Li SK, Tang HC, Man-Hon Leung M, Zou W, Chan WL, Zhou Y, Oi-Lin Ng I, Ching YP. Centrosomal protein TAX1BP2 inhibits centrosome-microtubules aberrations induced by hepatitis B virus X oncoprotein. Cancer Lett 2020;492:147-61. [PMID: 32827601 DOI: 10.1016/j.canlet.2020.08.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Wei L, Chiu DK, Tsang FH, Law CT, Cheng CL, Au SL, Lee JM, Wong CC, Ng IO, Wong CM. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J Hepatol 2017;67:758-69. [PMID: 28532996 DOI: 10.1016/j.jhep.2017.05.015] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 11.2] [Reference Citation Analysis]
35 Oztopcu-Vatan P, Sayitoglu M, Gunindi M, Inan E. Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells. Cytotechnology 2015;67:1003-9. [PMID: 24828824 DOI: 10.1007/s10616-014-9739-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
36 Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway. Liver Int 2012;32:752-60. [DOI: 10.1111/j.1478-3231.2011.02750.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 144] [Article Influence: 15.1] [Reference Citation Analysis]
37 Lefkowitch JH. Recent developments in liver pathology. Human Pathology 2009;40:445-55. [DOI: 10.1016/j.humpath.2008.12.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
38 Lv L, Wang P, Zhou X, Sun B. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk. Tumour Biol 2013;34:1451-9. [PMID: 23564481 DOI: 10.1007/s13277-013-0649-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
39 Su YH, Lin SY, Song W, Jain S. DNA markers in molecular diagnostics for hepatocellular carcinoma. Expert Rev Mol Diagn. 2014;14:803-817. [PMID: 25098554 DOI: 10.1586/14737159.2014.946908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
40 Li N, Zheng D, Xue J, Guo W, Shi J, Sun J, Lu C, Zheng W, Wu M, Cheng S. Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest. Exp Ther Med 2015;9:1709-18. [PMID: 26136881 DOI: 10.3892/etm.2015.2351] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
41 Berger E, Vega N, Weiss-Gayet M, Géloën A. Gene Network Analysis of Glucose Linked Signaling Pathways and Their Role in Human Hepatocellular Carcinoma Cell Growth and Survival in HuH7 and HepG2 Cell Lines. Biomed Res Int 2015;2015:821761. [PMID: 26380295 DOI: 10.1155/2015/821761] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
42 Ierardi E, Rosania R, Zotti M, Giorgio F, Prencipe S, Valle ND, Francesco VD, Panella C. From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways. World J Gastrointest Oncol 2010; 2(6): 259-264 [PMID: 21160638 DOI: 10.4251/wjgo.v2.i6.259] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
43 Li J, Wang T, Xia J, Yao W, Huang F. Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases. FASEB J 2019;33:11640-54. [PMID: 31370704 DOI: 10.1096/fj.201901175R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
44 Fan DN, Tsang FH, Tam AH, Au SL, Wong CC, Wei L, Lee JM, He X, Ng IO, Wong CM. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b. Hepatology. 2013;57:637-647. [PMID: 22991213 DOI: 10.1002/hep.26083] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
45 Liang HW, Wang N, Wang Y, Wang F, Fu Z, Yan X, Zhu H, Diao W, Ding Y, Chen X, Zhang CY, Zen K. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol. 2016;64:278-291. [PMID: 26409216 DOI: 10.1016/j.jhep.2015.09.013] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 10.3] [Reference Citation Analysis]
46 Fu S, Li N, Zhou PC, Huang Y, Zhou RR, Fan XG. Detection of HBV DNA and antigens in HBsAg-positive patients with primary hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2017;41:415-423. [PMID: 28286056 DOI: 10.1016/j.clinre.2017.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
47 Baek S, Cho KJ, Ju HL, Moon H, Choi SH, Chung SI, Park JY, Choi KH, Kim DY, Ahn SH, Han KH, Ro SW. Analysis of miRNA expression patterns in human and mouse hepatocellular carcinoma cells. Hepatol Res 2015;45:1331-40. [PMID: 25704452 DOI: 10.1111/hepr.12510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
48 Tamori A, Murakami Y, Kubo S, Itami S, Uchida-Kobayashi S, Morikawa H, Enomoto M, Takemura S, Tanahashi T, Taguchi YH, Kawada N. MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy. Hepatol Res 2016;46:E26-35. [PMID: 25788219 DOI: 10.1111/hepr.12518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
49 Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010;29:2309-24. [PMID: 20228847 DOI: 10.1038/onc.2010.36] [Cited by in Crossref: 184] [Cited by in F6Publishing: 173] [Article Influence: 15.3] [Reference Citation Analysis]
50 Zhao L, Zhang Y. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. Biochem Biophys Res Commun. 2015;457:370-377. [PMID: 25580008 DOI: 10.1016/j.bbrc.2014.12.119] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
51 Sze KM, Wong KL, Chu GK, Lee JM, Yau TO, Ng IO. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology. 2011;53:1558-1569. [PMID: 21520171 DOI: 10.1002/hep.24232] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 6.5] [Reference Citation Analysis]
52 Tsirulnikov K, Duarte S, Ray A, Datta N, Zarrinpar A, Hwang L, Faull K, Pushkin A, Kurtz I. Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma. J Cancer 2018;9:1-12. [PMID: 29290764 DOI: 10.7150/jca.21747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Kumar M, Zhao X, Wang XW. Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci. 2011;1:5. [PMID: 21711594 DOI: 10.1186/2045-3701-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Yang X, Zou P, Yao J, Yun D, Bao H, Du R, Long J, Chen X. Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma. J Proteome Res. 2010;9:1402-1415. [PMID: 20000738 DOI: 10.1021/pr900932y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
55 Hsiao PJ, Jao JC, Tsai JL, Chang WT, Jeng KS, Kuo KK. Inorganic arsenic trioxide induces gap junction loss in association with the downregulation of connexin43 and E-cadherin in rat hepatic "stem-like" cells. Kaohsiung J Med Sci 2014;30:57-67. [PMID: 24444534 DOI: 10.1016/j.kjms.2013.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
56 Salem NE, Saito M, Kasama Y, Ozawa M, Kawabata T, Harada S, Suda H, Asonuma K, El-Gohary A, Tsukiyama-Kohara K. Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences. Microbiol Immunol 2013;57:179-84. [PMID: 23277918 DOI: 10.1111/1348-0421.12025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
57 Shen DY, Fang ZX, You P, Liu PG, Wang F, Huang CL, Yao XB, Chen ZX, Zhang ZY. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver Int. 2010;30:119-125. [PMID: 19845855 DOI: 10.1111/j.1478-3231.2009.02106.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
58 Uccello M, Malaguarnera G, Pelligra EM, Biondi A, Basile F, Motta M. Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma. Indian J Med Paediatr Oncol 2011;32:71-5. [PMID: 22174493 DOI: 10.4103/0971-5851.89775] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
59 Wang ML, Miao F, Tang YH, Zhao XS, Zhong J, Yuan F. Special diaphragm-like strictures of small bowel unrelated to non-steroidal anti-inflammatory drugs. World J Gastroenterol 2011; 17(31): 3596-3604 [PMID: 21987606 DOI: 10.3748/wjg.v17.i31.3596] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
60 Lyra-González I, Flores-Fong LE, González-García I, Medina-Preciado D, Armendáriz-Borunda J. MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine. World J Hepatol 2015; 7(11): 1530-1540 [PMID: 26085912 DOI: 10.4254/wjh.v7.i11.1530] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
61 Yau T, Chan P, Epstein R, Poon RT. Management of advanced hepatocellular carcinoma in the era of targeted therapy. Liver Int 2009;29:10-7. [PMID: 19120940 DOI: 10.1111/j.1478-3231.2008.01916.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
62 Uno S, Endo K, Jeong Y, Kawana K, Miyachi H, Hashimoto Y, Makishima M. Suppression of beta-catenin signaling by liver X receptor ligands. Biochem Pharmacol 2009;77:186-95. [PMID: 18983830 DOI: 10.1016/j.bcp.2008.10.007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
63 Palaiologou M, Koskinas J, Karanikolas M, Fatourou E, Tiniakos DG. E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma. Virchows Arch. 2012;460:439-446. [PMID: 22450712 DOI: 10.1007/s00428-012-1220-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
64 Breuhahn K, Gores G, Schirmacher P. Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. Hepatology. 2011;53:2112-2121. [PMID: 21433041 DOI: 10.1002/hep.24313] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
65 Ou D, Yang H, Hua D, Xiao S, Yang L. Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma. Oncotarget 2015;6:17379-90. [PMID: 25978032 DOI: 10.18632/oncotarget.3954] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
66 Elhamamsy AR. DNA methylation dynamics in plants and mammals: overview of regulation and dysregulation. Cell Biochem Funct 2016;34:289-98. [PMID: 27003927 DOI: 10.1002/cbf.3183] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
67 Qesaraku B, Dudas J, Rave-Fränk M, Hess CF, Ramadori G, Saile B, Christiansen H. Effect of tumour necrosis factor-alpha and irradiation alone or in combination on the viability of hepatocellular and biliary adenocarcinoma cell lines in vitro. Liver Int 2009;29:910-21. [PMID: 19226333 DOI: 10.1111/j.1478-3231.2009.01980.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Ionta M, Rosa MC, Almeida RB, Freitas VM, Rezende-Teixeira P, Machado-Santelli GM. Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation. Braz J Med Biol Res. 2012;45:721-729. [PMID: 22618858 DOI: 10.1590/S0100-879X2012007500087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
69 Bozkaya G, Korhan P, Cokaklı M, Erdal E, Sağol O, Karademir S, Korch C, Atabey N. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Mol Cancer 2012;11:64. [PMID: 22962849 DOI: 10.1186/1476-4598-11-64] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
70 Wong CM, Wong CC, Lee JM, Fan DN, Au SL, Ng IO. Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis. Hepatology. 2012;55:1453-1461. [PMID: 22135159 DOI: 10.1002/hep.25512] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 6.9] [Reference Citation Analysis]
71 Hao PP, Li H, Lee MJ, Wang YP, Kim JH, Yu GR, Lee SY, Leem SH, Jang KY, Kim DG. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression. J Hepatol 2015;62:1278-86. [PMID: 25617504 DOI: 10.1016/j.jhep.2014.12.033] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
72 Xiangbing H, Yankai Z, Ming L, Yong L, Yu Z, Huiyong Z, Yingying C, Jing H, Yun X, Liang J, Rongyue C, Jingjing L. The fusion protein of HSP65 with tandem repeats of β-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma. International Immunopharmacology 2010;10:230-8. [DOI: 10.1016/j.intimp.2009.11.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
73 Wang ZM, Zhou LY, Liu BB, Jia QA, Dong YY, Xia YH, Ye SL. Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells. Mol Med Rep 2014;10:1725-33. [PMID: 25109274 DOI: 10.3892/mmr.2014.2435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
74 Tung EK, Wong BY, Yau TO, Ng IO. Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion. PLoS One. 2012;7:e36565. [PMID: 22570728 DOI: 10.1371/journal.pone.0036565] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
75 Yang Y, Wang JB, Li YM, Zhao YU, Wang R, Wu Q, Zheng RS, Ou YR. Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma. Oncol Lett 2016;12:429-36. [PMID: 27347162 DOI: 10.3892/ol.2016.4622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
76 Ganslmayer M, Zimmermann A, Zopf S, Herold C. Combined inhibitors of angiogenesis and histone deacetylase: Efficacy in rat hepatoma. World J Gastroenterol 2011; 17(31): 3623-3629 [PMID: 21987609 DOI: 10.3748/wjg.v17.i31.3623] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
77 He H, Baldwin GS. p21-activated kinases and gastrointestinal cancer. Biochim Biophys Acta. 2013;1833:33-39. [PMID: 23092728 DOI: 10.1016/j.bbamcr.2012.10.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
78 Xu L, Wang P, Feng X, Tang J, Li L, Zheng X, Zhang J, Hu Y, Lan T, Yuan K, Zhang Y, Ren S, Hao X, Zhang M, Xu M. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma. Clin Sci (Lond) 2019;133:2085-105. [PMID: 31654063 DOI: 10.1042/CS20190666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
79 Wong CM, Wei L, Law CT, Ho DW, Tsang FH, Au SL, Sze KM, Lee JM, Wong CC, Ng IO. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis. Hepatology 2016;63:474-87. [PMID: 26481868 DOI: 10.1002/hep.28304] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 12.7] [Reference Citation Analysis]
80 Hsu HT, Wu PR, Chen CJ, Hsu LS, Yeh CM, Hsing MT, Chiang YS, Lai MT, Yeh KT. High cytoplasmic expression of Krüppel-like factor 4 is an independent prognostic factor of better survival in hepatocellular carcinoma. Int J Mol Sci. 2014;15:9894-9906. [PMID: 24897024 DOI: 10.3390/ijms15069894] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
81 Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, Dipaola RS, Karantza-Wadsworth V, White E. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009;137:1062-75. [PMID: 19524509 DOI: 10.1016/j.cell.2009.03.048] [Cited by in Crossref: 1151] [Cited by in F6Publishing: 1140] [Article Influence: 88.5] [Reference Citation Analysis]
82 Ahmed HH, Khalil WKB, Hamza AH. Molecular mechanisms of Nano-selenium in mitigating hepatocellular carcinoma induced by N -nitrosodiethylamine (NDEA) in rats. Toxicology Mechanisms and Methods 2014;24:593-602. [DOI: 10.3109/15376516.2014.956912] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
83 Zhang RJ, Zou YB, Gao RP, Zhang XJ, Zhu J. Expression and roles of connective tissue growth factor in human primary hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2010; 18(26): 2775-2779 [DOI: 10.11569/wcjd.v18.i26.2775] [Reference Citation Analysis]
84 Tung EK, Ng IO. Significance of serum DKK1 as a diagnostic biomarker in hepatocellular carcinoma. Future Oncol. 2012;8:1525-1528. [PMID: 23231514 DOI: 10.2217/fon.12.147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
85 Pivonello C, De Martino MC, Negri M, Cuomo G, Cariati F, Izzo F, Colao A, Pivonello R. The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets. Infect Agent Cancer 2014;9:27. [PMID: 25225571 DOI: 10.1186/1750-9378-9-27] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
86 Yau T, Pang R, Chan P, Poon RT. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib. Expert Opinion on Pharmacotherapy 2010;11:2187-98. [DOI: 10.1517/14656561003724705] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
87 Ceballos MP, Rigalli JP, Ceré LI, Semeniuk M, Catania VA, Ruiz ML. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Curr Med Chem 2019;26:1224-50. [PMID: 29303075 DOI: 10.2174/0929867325666180105103637] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
88 Wang Y, Wan G, Wang H, Zhang G, Li Z, Lu L, Wu Y, Yu X, Du J. Mechanism of aberrant long non-coding RNA expression in an adriamycin-resistant liver cancer cell strain. Dig Liver Dis 2020;52:582-7. [PMID: 31704308 DOI: 10.1016/j.dld.2019.09.013] [Reference Citation Analysis]
89 Au J, Frenette C. Development of Tivantinib as Treatment for Hepatocellular Carcinoma. J Clin Transl Hepatol 2013;1:75-8. [PMID: 26355274 DOI: 10.14218/JCTH.2013.00008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
90 Sun B, Karin M. NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene. 2008;27:6228-6244. [PMID: 18931690 DOI: 10.1038/onc.2008.300] [Cited by in Crossref: 194] [Cited by in F6Publishing: 182] [Article Influence: 13.9] [Reference Citation Analysis]
91 Notarbartolo M, Giannitrapani L, Vivona N, Poma P, Labbozzetta M, Florena AM, Porcasi R, Muggeo VM, Sandonato L, Cervello M. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. OMICS. 2011;15:267-272. [PMID: 21332389 DOI: 10.1089/omi.2010.0096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
92 Ko FC, Yeung YS, Wong CM, Chan LK, Poon RT, Ng IO, Yam JW. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma. Liver Int 2010;30:139-48. [PMID: 19874489 DOI: 10.1111/j.1478-3231.2009.02133.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
93 Qian Y, Li Y, Zheng C, Lu T, Sun R, Mao Y, Yu S, Fan H, Zhang Z. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas. Cancer Genet 2020;245:17-26. [PMID: 32534446 DOI: 10.1016/j.cancergen.2020.04.077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Bharali D, Banerjee BD, Bharadwaj M, Husain SA, Kar P. Expression analysis of apolipoproteins AI & AIV in hepatocellular carcinoma: A protein-based hepatocellular carcinoma-associated study. Indian J Med Res 2018;147:361-8. [PMID: 29998871 DOI: 10.4103/ijmr.IJMR_1358_16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]